Next, the distribution of the genetic causes and clinical phenotypes of the affected individuals were investigated, but no pattern could be identified that indicated a large difference between the genetic groups or between bvFTD and PPA connected to the levels of NEFM, NPTX2, VGF and AQP4 (Supplementary Fig. 2B). This evidence concerns the gene AQP4 and primary progressive aphasia.